New macroeconomic simulation study in PLOS ONE

Total economic burden of non-communicable disease in the US over the time span 2015-2050 averages at 10.8% of GDP.

In a macroeconomic simulation study published in PLOS ONE, a team, including M. Kuhn assess the drag that non-communicable diseases impose on GDP growth in the US. About 61% can be attributed to reductions in human capital through mortality and morbidity and about 39% to lower physical capital accumulation because of treatment costs. Mental health and cardiovascular disease impose largest burden, followed by cancer, diabetes and respiratory disease.